Search results
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 6 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 5 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 3 days agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program - Moderna...
Benzinga· 3 days agoThursday, the FDA selected Moderna Inc’s MRNA mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program. “Selection for this ...
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 3 days agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program
Morningstar· 3 days agoBy Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing ...
Moderna's RSV Vaccine Approved by FDA
Medscape· 7 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 6 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 7 days agoThe FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31. "This approval ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...